Zacks Investment Research downgraded shares of SOLTA MEDICAL (SLTM) from NEUTRAL to UNDERPERFORM on May 03, 2012, with a target price of $3.00.
Solta Medical, Inc. provides aesthetic and therapeutic solutions for patients. It offers Thermage, a non-invasive radiofrequency procedure for tightening and contouring skin and Fraxel, which delivers invasive clinical solutions to resurface aging and sun damaged skin. This procedure can be performed on any part of the body where treatment of wrinkles is desired. The company is headquartered in Hayward, California.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on SOLTA MEDICAL (SLTM),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment